MELINIA HONJO: Open Payments
NPI 1386713147 · LOS GATOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,060 in 57 payments from 16 companies in 2025. Trend: 2023 $41 · 2024 $361 · 2025 $1,060
Food & beverage: $1,050Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $174 |
| Janssen Biotech, Inc. | 8 | $151 |
| Organon LLC | 9 | $107 |
| GENZYME CORPORATION | 4 | $107 |
| UCB, Inc. | 4 | $105 |
| Incyte Corporation | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 2 | $59 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| Amgen Inc. | 3 | $56 |
| Botanix SB Inc | 2 | $46 |
Products named: TREMFYA, SKYRIZI, VTAMA, Bimzelx, DUPIXENT, OPZELURA, COSENTYX, OTEZLA.
Industry payments across CA — which companies pay providers there.
